Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
Study sponsor: Disc Medicine, Inc · IRON
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-02-20Actual
Enrollment · participants75Actual
Source updated2026-01-08Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.